Table 2 Associations of tumor characteristics with the TLI status.
From: Is the thymidine labeling index a good prognostic marker in breast cancer?
All patients | Patients with TLI-low | Patients with TLI-high | p-value | ||||
|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Histologic type | 0.556 | ||||||
Invasive ductal | 182 | 67.9 | 72 | 39.6 | 110 | 60.4 | |
Invasive lobular | 18 | 6.7 | 9 | 50.0 | 9 | 50.0 | |
Mixed ductal&lobular | 50 | 18.7 | 18 | 36.0 | 32 | 64.0 | |
Other | 18 | 6.7 | 5 | 27.8 | 13 | 72.2 | |
Multifocality + Multicentricity | 0.456 | ||||||
Yes | 34 | 12.7 | 11 | 32.4 | 23 | 67.6 | |
No | 234 | 87.3 | 93 | 39.7 | 141 | 60.3 | |
Nuclear Grade | 0.008 | ||||||
1+2 | 177 | 66 | 79 | 44.6 | 98 | 55.4 | |
3 | 91 | 34 | 25 | 27.5 | 66 | 72.5 | |
Histologic Grade | 0.999 | ||||||
1+2 | 136 | 50.7 | 53 | 39.0 | 83 | 61.0 | |
3 | 132 | 49.3 | 51 | 38.6 | 81 | 61.4 | |
Lymphovascular invasion | 0.753 | ||||||
Yes | 206 | 76.9 | 81 | 39.3 | 125 | 60.7 | |
No | 62 | 23.1 | 23 | 37.1 | 39 | 62.9 | |
Estrogen receptor (ER) status | 0.124 | ||||||
ER-positive | 173 | 64.6 | 73 | 42.2 | 100 | 57.8 | |
ER-negative | 95 | 35.4 | 31 | 32.6 | 64 | 67.4 | |
Progesteron receptor (PR) status | 0.134 | ||||||
PR-positive | 69 | 25.7 | 32 | 46.4 | 37 | 53.6 | |
PR-negative | 199 | 74.3 | 72 | 36.2 | 127 | 63.8 | |